It's Time for the Epstein Story to Be Buried
A New Poll Shows Old Media Resistance, and Nicolle Wallace Decides Which Country...
Is Free Speech Really the Highest Value?
Dan Patrick Was Right — Carrie Prejean Boller Had to Go
The Antisemitism Broken Record
Before Protesting ICE, Learn How Government Works
Republican Congress Looks Like a Democrat Majority on TV News
Immigration Is Shaking Up Political Parties in Britain, Europe and the US
Representing the United States on the World Stage Is a Privilege, Not a...
Older Generations Teach the Lost Art of Romance
Solving the Just About Unsolvable Russo-Ukrainian War
20 Alleged 'Free Money' Gang Members Indicted in Houston on RICO, Murder, and...
'Green New Scam' Over: Trump Eliminates 2009 EPA Rule That Fueled Unpopular EV...
Tim Walz Wants Taxpayers to Give $10M in Forgivable Loans to Riot-Torn Businesses
The SAVE Act Fight Ends When It Lands on Trump's Desk for Signature
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’
AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos